Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Advanced Medical Solutions ( (GB:AMS) ) has shared an announcement.
Advanced Medical Solutions Group plc has announced its total issued share capital as of December 31, 2024, which includes 217,864,092 ordinary shares with voting rights, helping shareholders determine notification requirements under FCA rules. This update provides stakeholders with clarity on their shareholding status, reinforcing transparency and compliance with regulatory standards.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer specializing in innovative tissue-healing technologies. The company offers a wide range of surgical products, including tissue adhesives, sutures, haemostats, and internal sealants under various brands such as LiquiBand®, RESORBA®, and Seal-G®. Additionally, AMS produces wound care dressings through its ActivHeal® brand and supplies products globally via multinational partners and its own direct sales forces. Established in 1991, AMS has expanded its operations worldwide, employing over 1,500 people and maintaining R&D hubs in several countries.
YTD Price Performance: -3.97%
Average Trading Volume: 497,677
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £422.3M
See more data about AMS stock on TipRanks’ Stock Analysis page.
